|
Market Closed -
Nasdaq
07:00:00 10/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 168.35 USD | -1.02% |
|
-6.08% | -7.82% |
| 08/10 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
| 29/09 | Deutsche Bank Lowers Price Target on Axsome Therapeutics to $267 From $280, Keeps Buy Rating | MT |
| Market Cap | 8.82B 7.88B 7.33B 6.66B 12.58B 853B 12.64B 88.18B 34.55B 435B 33.11B 32.39B 1,396B | P/E 2026 * |
-61.4x | P/E 2027 * | 38x |
|---|---|---|---|---|---|
| Enterprise Value | 8.67B 7.74B 7.2B 6.55B 12.37B 839B 12.43B 86.7B 33.97B 428B 32.56B 31.85B 1,373B | EV / Sales 2026 * |
9.01x | EV / Sales 2027 * | 5.44x |
| Free-Float |
84.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AXSM | Delayed | |
CBOE
| AXSM | Real-time | |
Deutsche Boerse AG
| 19X | Delayed | |
London S.E.
| 0HKF | Delayed | |
Tradegate
| 19X | Real-time | |
Börse Stuttgart
| 19X | Delayed | |
Boerse Muenchen
| 19X | Real-time | |
Borsa Italiana
| 1AXSM | End-of-day quote | |
Xetra
| 19X | Delayed |
Last Transcript: Axsome Therapeutics, Inc.
| 1 day | -1.02% | ||
| 1 week | -6.08% | ||
| Current month | -8.70% | ||
| 1 month | -20.26% | ||
| 3 months | -27.99% | ||
| 6 months | -5.48% | ||
| Current year | -7.82% |
| 1 week | 166.12 | 179.7 | |
| 1 month | 166.12 | 223.29 | |
| Current year | 152.28 | 260.19 | |
| 1 year | 119.2 | 260.19 | |
| 3 years | 55.02 | 260.19 | |
| 5 years | 20.63 | 260.19 | |
| 10 years | 1.94 | 260.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 12/01/2012 | |
Nick Pizzie
DFI | Director of Finance/CFO | 51 | 16/05/2018 |
Mark Jacobson
COO | Chief Operating Officer | 42 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 12/01/2012 | |
Roger Jeffs
BRD | Director/Board Member | 64 | 01/12/2014 |
Mark Coleman
BRD | Director/Board Member | 58 | 01/12/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Exercice | Chief Operating Officer | 30,000 | 0.0573% | ||
| 6/8/26 | Exercice | Chief Executive Officer | 13,980 | 0.0272% | ||
| 1/7/26 | Exercice | Chief Executive Officer | 148,998 | 0.2895% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.02% | -6.08% | +38.32% | +138.59% | 8.82B | ||
| +0.83% | +3.19% | +41.49% | +103.56% | 1,051B | ||
| +1.93% | +2.11% | +37.08% | +65.09% | 630B | ||
| +1.49% | +5.19% | +19.94% | +85.69% | 489B | ||
| +2.26% | +0.90% | +69.32% | +40.53% | 359B | ||
| +1.45% | +3.50% | +23.29% | +41.62% | 344B | ||
| +1.17% | +2.37% | +13.47% | +33.64% | 272B | ||
| +0.89% | +1.08% | -6.13% | +9.29% | 246B | ||
| +1.82% | +2.94% | +42.99% | +52.95% | 224B | ||
| +2.77% | +4.44% | +29.01% | +98.99% | 187B | ||
| Average | +1.36% | +1.67% | +30.88% | +66.99% | 381.25B | |
| Weighted average by Cap. | +1.46% | +2.42% | +33.37% | +69.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 963M 860M 800M 728M 1.37B 93.18B 1.38B 9.63B 3.77B 47.5B 3.62B 3.54B 152B | 1.54B 1.38B 1.28B 1.17B 2.2B 150B 2.21B 15.45B 6.05B 76.22B 5.8B 5.67B 245B |
| Net income | -144M -129M -120M -109M -206M -13.96B -207M -1.44B -565M -7.12B -542M -530M -22.84B | 244M 218M 203M 184M 348M 23.59B 349M 2.44B 955M 12.03B 915M 895M 38.6B |
| Net Debt | -148M -132M -123M -112M -211M -14.29B -212M -1.48B -578M -7.28B -554M -542M -23.37B | -421M -376M -350M -318M -601M -40.74B -603M -4.21B -1.65B -20.77B -1.58B -1.55B -66.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/10/26 | USD 168.35 | -1.02% | 894,518 |
| 08/10/26 | USD 170.08 | -1.67% | 1,073,755 |
| 07/10/26 | USD 172.97 | -0.79% | 887,361 |
| 06/10/26 | USD 174.34 | -1.55% | 1,367,835 |
| 05/10/26 | USD 177.08 | -1.21% | 858,894 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AXSM Stock
Select your edition
All financial news and data tailored to specific country editions

















